Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > The real question is

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Jul 25, 2021 4:29pm

75 Views

Post# 33602350

RE:RE:RE:The real question is

Which deal are you referring to?

SPCEO1 wrote: You really cannot put a price on it until you see the terms of the deal. It may turn out those terms are really good and $5 would look like a foloishly low price to sell at. I am just hoping for a higher price so that the average price of any stock sold under the ATM and the OO/NO is more palatable.

palinc2000 wrote: My reaction will be as follows

5ish and over------Elated
4 ish -neutral
Under 4 -Disappointed

palinc2000 wrote: What is the minimum price that THTX will accept for issuing shares under the ATM?
I wrote that I would be elated at 5 usd ,